NT-KO-003 ( DrugBank: - )

---

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
13	多発性硬化症／視神経脊髄炎	1

13. 多発性硬化症／視神経脊髄炎

---

臨床試験数 : 3,342 /  薬物数 : 2,355 - (DrugBank : 406) / 標的遺伝子数 : 269 - 標的パスウェイ数 : 241

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01428726 (ClinicalTrials.gov)	June 2011	31/8/2011	A Phase IIa Study of NT-KO-003 for Multiple Sclerosis	A Phase IIa Multicenter Double Blind Study to Evaluate the Efficacy and Safety of Low Doses of Oral NT-KO-003 for the Treatment of Multiple Sclerosis	Relapsing Remitting Multiple Sclerosis	Drug: NT-KO-003	Neurotec Pharma	Advancell - Advanced In Vitro Cell Technologies, S.A.	Completed	18 Years	55 Years	Both	99	Phase 2	Germany;Spain